In a patient on bisoprolol, how does adrenaline (epinephrine) affect heart rate and contractility, and what dosing adjustments or precautions are needed when using it for anaphylaxis, cardiac arrest, or severe bronchospasm?

Bisoprolol and Adrenaline Interaction

In patients on bisoprolol, epinephrine (adrenaline) remains the first-line treatment for anaphylaxis, cardiac arrest, and severe bronchospasm, but these patients are at high risk for refractory hypotension, paradoxical bradycardia, and treatment failure—requiring glucagon administration (1-5 mg IV bolus followed by 5-15 mcg/min infusion) and aggressive fluid resuscitation. 1

Mechanism of the Interaction

Bisoprolol blocks β-adrenergic receptors, fundamentally altering how epinephrine works in the body. When you give epinephrine to a β-blocked patient:

• Unopposed α-adrenergic effects dominate, causing severe vasoconstriction and paradoxical hypertension
• Reflex vagotonic effects are triggered, leading to profound bradycardia (heart rates as low as 28 bpm have been documented) 2
• Blunted cardiac contractility persists because β1-receptors remain blocked
• Bronchospasm risk increases due to β2-receptor blockade 1

The net result: epinephrine may paradoxically worsen anaphylaxis through these unopposed effects, and patients experience decreased cardiac contractility with perpetuation of hypotension and bradycardia 1.

Clinical Management Algorithm

For Anaphylaxis in β-Blocked Patients:

1. Give standard-dose epinephrine immediately (0.3-0.5 mg IM, 1:1000 solution in anterolateral thigh) 3

   • Do NOT withhold epinephrine—it remains first-line despite β-blockade
   • Repeat every 5-15 minutes as needed

2. Anticipate treatment failure and prepare glucagon early:

   • Glucagon 1-5 mg IV bolus over 5 minutes (20-30 mcg/kg up to 1 mg in children) 1
   • Follow with continuous infusion 5-15 mcg/min, titrated to clinical response
   • Glucagon works independently of β-receptors by increasing intracellular cAMP
   • Critical caveat: Glucagon causes nausea and vomiting—maintain aspiration precautions 1

3. Aggressive fluid resuscitation is mandatory:

   • Anaphylaxis causes 50% of intravascular volume to shift extravascularly within 10 minutes 1
   • Adults: 1-2 L normal saline at 5-10 mL/kg in first 5 minutes 1
   • Children: up to 30 mL/kg in first hour 1
   • β-blocked patients respond better to volume than to epinephrine alone 1

4. If hypotension persists after 2-3 epinephrine doses:

   • Consider IV epinephrine infusion (5-15 mcg/min, titrated) 3
   • Add dopamine 2-20 mcg/kg/min if needed 1
   • Continuous hemodynamic monitoring is essential 1

For Cardiac Arrest in β-Blocked Patients:

1. Standard ACLS with high-dose epinephrine:

   • Initial: 1-3 mg IV (1:10,000) over 3 minutes
   • Then: 3-5 mg IV over 3 minutes
   • Then: 4-10 mg/min continuous infusion 1
   • Children: 0.01 mg/kg (0.1 mL/kg of 1:10,000) every 3-5 minutes 1

2. Administer glucagon immediately (same dosing as above) 4

3. Massive fluid resuscitation 4

4. Consider ECPR if refractory—case reports show survival with favorable neurologic outcomes 4

5. Prolonged resuscitation efforts are justified—anaphylaxis patients are typically young with healthy cardiovascular systems 1

For Severe Bronchospasm:

• Epinephrine IM remains first-line (standard dosing)
• Add nebulized albuterol 2.5-5 mg in 3 mL saline, repeat as needed 1
• Glucagon if refractory (works on bronchial smooth muscle independently of β-receptors)
• Consider endotracheal epinephrine 0.5 mg (1:10,000) in 10 mL saline as last resort 5

Critical Pitfalls to Avoid

1. Dosing Confusion Leading to Iatrogenic Overdose

The cardiac arrest dose of epinephrine (1 mg IV) is 10-20 times higher than the anaphylaxis dose (0.05-0.1 mg IV). Giving cardiac arrest doses to conscious anaphylaxis patients causes severe systolic dysfunction and potentially lethal cardiac complications 6. Always verify:

• Anaphylaxis IM: 0.3-0.5 mg of 1:1000 solution
• Anaphylaxis IV (if line in place): 0.05-0.1 mg of 1:10,000 solution 3
• Cardiac arrest IV: 1 mg of 1:10,000 solution

2. Underestimating Fluid Requirements

β-blocked patients have maximal compensatory vasoconstriction that makes vasopressors less effective 1. They respond better to aggressive volume replacement than additional epinephrine.

3. Delayed Glucagon Administration

Glucagon should be prepared and ready when treating β-blocked patients with anaphylaxis, not considered only after multiple epinephrine failures 1.

4. Monitoring Potassium Levels

Multiple doses of epinephrine cause severe hypokalemia (nadir 2.1 mmol/L reported) through β2-mediated intracellular potassium shift, leading to critical QT prolongation and arrhythmia risk 7. Check potassium levels and supplement proactively when using continuous or multiple epinephrine doses.

Evidence Quality and Nuances

The recommendations for glucagon in β-blocked anaphylaxis come from established guidelines 1 based on pathophysiology and case series rather than randomized trials. However, a 2018 observational study 8 found that β-blocker use did not increase the need for repeat epinephrine doses in emergency department anaphylaxis patients (OR 1.26,95% CI 0.58-2.75). This suggests that while the pharmacologic interaction is real and potentially catastrophic, most β-blocked patients respond adequately to standard epinephrine dosing. The key is recognizing the subset who don't respond and having glucagon immediately available.

The 2025 AHA guidelines 4 now explicitly recommend glucagon for refractory anaphylaxis in β-blocked patients, with emphasis on not delaying standard ACLS/PALS protocols.

Practical Monitoring Requirements

When using IV epinephrine in β-blocked patients:

• Continuous cardiac monitoring (watch for severe bradycardia and hypertension) 1
• Blood pressure every 1 minute 1
• Pulse oximetry 1
• Serum potassium if multiple doses given 7